Analytical Data
-
基因名
CLM-5
- Application
-
别名
CLM-5; CLM 5; CMRF35-A4; CMRF35 A4; CD300LD
-
种属
Human
-
表达系统
HEK293
-
标签
C-hFc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q6UXZ3
-
表达区间
A19-H165
-
蛋白长度
Extracellular Domain
-
分子量
55-70 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CLM-5, a recombinant protein derived from the CLM family, has garnered significant attention in recent years due to its potential applications in therapeutic and biotechnological fields. The CLM (C-type lectin-like) protein family is known for its involvement in various biological processes, including immune response regulation, cell adhesion, and pathogen recognition. Research indicates that CLM-5 may play a crucial role in modulating immune responses, making it a candidate for developing novel immunotherapies, especially in cancer treatment and infectious diseases. The recombinant production of CLM-5 allows for the generation of large quantities of the protein for functional studies, structural analysis, and potential clinical applications. Furthermore, understanding the molecular mechanisms by which CLM-5 interacts with specific receptors and cells could provide insights into its role in influencing immune pathways. As research progresses, CLM-5 is being explored for its capabilities in enhancing vaccine efficacy and promoting a balanced immune response. Overall, the study of CLM-5 as a recombinant protein embodies a promising frontier in immunology and therapeutic innovations, with the potential to address critical health challenges.
